Parkman Healthcare Partners’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Sell |
817,808
-141,895
| -15% | -$529K | 0.35% | 71 |
|
|
2025
Q1 | $2.65M | Buy |
959,703
+130,598
| +16% | +$360K | 0.31% | 69 |
|
|
2024
Q4 | $4.59M | Buy |
829,105
+283,354
| +52% | +$1.57M | 0.61% | 47 |
|
|
2024
Q3 | $4.55M | Buy |
545,751
+155,481
| +40% | +$1.3M | 0.58% | 56 |
|
|
2024
Q2 | $2.66M | Buy |
+390,270
| New | +$2.66M | 0.36% | 67 |
|
|
2023
Q4 | – | Sell |
-41,728
| Closed | -$210K | – | 104 |
|
|
2023
Q3 | $210K | Sell |
41,728
-60,697
| -59% | -$305K | 0.04% | 102 |
|
|
2023
Q2 | $896K | Buy |
102,425
+27,425
| +37% | +$240K | 0.16% | 88 |
|
|
2023
Q1 | $888K | Buy |
+75,000
| New | +$888K | 0.19% | 73 |
|